Analyst Ratings for BioMarin Pharmaceutical Inc. (BMRN) [Neutrals]

BMRN Rating Summary

BMRN Price Target Summary

* Over Last 12-Mos
  |   Expand Research on BMRN
Overall Rating: BUY   Rating Trend: Down   Avg. $ Target: $106.40 (+25.7%) * Over Last 12-Mos
Rating Score: 7.7 / 10   Percentile Rank: 85%
Date Firm Type Rating
(Past)
PT
(Past)
Start $ End $ % Chg. Details
11/29/2016 Barclays Downgrade Equalweight
(Overweight)
105.00
(125.00)
88.36 84.62 -4.23% Details
11/7/2016 Piper Jaffray Downgrade Neutral
(Overweight)
84.00
(105.00)
82.00 84.62 3.2% Details
Like BMRN Ratings? Also take a look at SNY, SRPT, VRTX, INCY

BMRN Ratings News